AIDX · Forms 3, 4, 5
Insider trades at 20/20 Biolabs, Inc.
No open-market insider buys or sells at 20/20 Biolabs, Inc. in the last 90 days; 10 filings reported awards, option exercises, tax withholding or new insiders.
Every Form 3, 4 and 5 filed for 20/20 Biolabs, Inc. (AIDX) with the SEC, newest first: who traded, their role, buy or sell, shares, price and value.
Most recent insider filings
No Form 3, 4 or 5 filings for 20/20 Biolabs, Inc. in the last 90 days. The latest ones on EDGAR:
| Date | Insider | Role | Transaction | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Alan B. Bergman | Chief Financial Officer | Options or other derivatives | Form 4 | ||||
| Jiming Zhou | Chief Operating Officer | Options or other derivatives | Form 4 | ||||
| Jonathan M Cohen | Chief Executive Officer | Options or other derivatives | Form 4 | ||||
| John Woodson Rollins | Director | Became an insider (Form 3) | Form 3 | ||||
| John Woodson Rollins | Director | Conversion | 13,029 | Form 4 | |||
| John Woodson Rollins | Director | Conversion | 6,135 | Form 4 | |||
| Michael A. Ross | Director | Conversion | 31 | Form 4 | |||
| John G. Compton | Director | Conversion | 7,669 | Form 4 | |||
| Richard M Cohen | Director | Conversion | 7,700 | Form 4 | |||
| Jonathan M Cohen | Chief Executive Officer | Became an insider (Form 3) | Form 3 | ||||
| Michael Saul Lebowitz | Chief Scientific Officer | Became an insider (Form 3) | Form 3 |
Buy and Sell are open-market purchases and sales (transaction codes P and S), the trades investors watch. Awards, option exercises, tax withholding and gifts are reported too but are not market trades.